Quantum Biopharma (QNTM) Non-Current Assets (2018 - 2026)

Quantum Biopharma's Non-Current Assets history runs 9 years deep, the most recent figure standing at $4.6 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 7.78% year-over-year to $4.6 million; the TTM figure through Mar 2026 stood at $19.3 million (up 267.26% YoY), while the FY2023 annual figure was $5.5 million, down 58.24% from the prior year.
• Non-Current Assets came in at $4.6 million for Q1 2026 at Quantum Biopharma, down from $4.8 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $13.1 million in Q4 2022 to a low of $4.6 million in Q1 2026.
• A 5-year average of $6.0 million and a median of $5.1 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets slumped 58.24% in 2023 and declined 5.2% in 2025, its largest moves.
• Quantum Biopharma's Non-Current Assets stood at $13.1 million in 2022, then plunged by 58.24% to $5.5 million in 2023, then slipped by 5.45% to $5.2 million in 2024, then decreased by 7.2% to $4.8 million in 2025, then dropped by 5.26% to $4.6 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $4.6 million, $4.8 million, and $5.0 million for Q1 2026, Q3 2025, and Q2 2025 respectively.

Peer Comparison